Human astrocytic bradykinin B2 receptor modulates zymosan-induced cytokine expression in 1321N1 cells

Peptides

Volumn 31, Issue 1, 2010, Pages 101-107

  Kim, Donghoon ^a   Cho, Suk Hee ^a   Kim, Jong So ^b   Jo, Su Hyun ^c   Lee, Sung Joong ^a   Kim, Kyong Tai ^b   Choi, Se Young ^a  

^a School of Dentistry   (South Korea)

^b Pohang University of Science and Technology (POSTECH)   (South Korea)

^c Kangwon National University   (South Korea)

Author keywords

Astrocyte; Bradykinin; Cytokine; Phospholipase C; Toll like receptor

Indexed keywords

ARGININE; BRADYKININ B2 RECEPTOR; CALCIUM ION; CYCLOOXYGENASE 2; CYTOKINE; INOSITOL 1,4,5 TRISPHOSPHATE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; KALLIDIN DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; ZYMOSAN;

ANIMAL CELL; ARTICLE; ASTROCYTE; ASTROCYTOMA CELL; CONTROLLED STUDY; CYTOSOL; GLIOMA CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT;

ANIMALS; ASTROCYTES; BRADYKININ; CALCIUM SIGNALING; CELL LINE, TUMOR; CYTOKINES; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; RATS; RECEPTOR, BRADYKININ B2; SPECIES SPECIFICITY; TOLL-LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR-ALPHA; ZYMOSAN;

RATTUS;

EID: 73049087784     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2009.10.011     Document Type: Article

References (38)

1. Abbott N.J., Rönnbäck L., and Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7 (2006) 41-53
2. Aragay A.M., Collins L.R., Post G.R., Watson A.J., Feramisco J.R., Brown J.H., et al. G12 requirement for thrombin-stimulated gene expression and DNA synthesis in 1321N1 astrocytoma cells. J Biol Chem 270 (1995) 20073-20077
3. 2 receptor. Mol Pharmacol 52 (1997) 16-20
4. Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430 (2004) 257-263
5. Bhoola K.D., Figueroa C.D., and Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev 44 (1992) 1-80
6. 2-mediated cAMP production during neuronal differentiation of human neuroblastoma SK-N-BE(2)C cells. J Neurochem 79 (2001) 303-310
7. 2 bradykinin binding sites on cultured cortical astrocytes. J Neurochem 57 (1991) 1456-1458
8. 2-mediated inhibition. Nature 411 (2001) 957-962
9. 9]BK: influence of enalaprilat. Am J Physiol Heart Circ Physiol 271 (1996) H1340-H1347
10. Dong Y., and Benveniste E.N. Immune function of astrocytes. Glia 36 (2001) 180-190
11. Easton A.S., and Abbott N.J. Bradykinin increases permeability by calcium and 5-lipoxygenase in the ECV304/C6 cell culture model of the blood-brain barrier. Brain Res 953 (2002) 157-169
12. 2 receptors in the rabbit and the guinea pig. Can J Physiol Pharmacol 74 (1996) 137-144
13. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260 (1985) 3440-3450
14. 2 expression via sequential PKC-δ, p42/p44 MAPK, and NF-κB activation in rat brain astrocytes. J Cell Physiol 206 (2006) 246-254
15. 2+ exchanger. J Neurosci 27 (2007) 13065-13073
16. Konat G.W., Krasowska-Zoladek A., and Kraszpulski M. Statins enhance toll-like receptor 4-mediated cytokine gene expression in astrocytes: implication of Rho proteins in negative feedback regulation. J Neurosci Res 86 (2008) 603-609
17. Lai J., Luo M.C., Chen Q., Ma S., Gardell L.R., Ossipov M.H., et al. Dynorphin A activates bradykinin receptors to maintain neuropathic pain. Nat Neurosci 9 (2006) 1534-1540
18. Lee C.J., Mannaioni G., Yuan H., Woo D.H., Gingrich M.B., and Traynelis S.F. Astrocytic control of synaptic NMDA receptors. J Physiol 581 (2007) 1057-1081
19. Leeb-Lundberg L.M., Marceau F., Müller-Esterl W., Pettibone D.J., and Zuraw B.L. International union of pharmacology, XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev 57 (2005) 27-77
20. 2 receptor antagonist in a rat model of temporary focal cerebral ischemia. Brain Res 1069 (2006) 227-234
21. Marceau F., and Regoli D. Bradykinin receptor ligands: therapeutic perspectives. Nat Rev Drug Discov 3 (2004) 845-852
22. 2 derived from enteric glial cells in the action of bradykinin in cultured rat myenteric neurons. Neuroscience 145 (2007) 642-653
23. 2 receptors in sheep brain and spinal cord visualized by in vitro autoradiography. J Comp Neurol 381 (1997) 203-218
24. Noda M., Kariura Y., Pannasch U., Nishikawa K., Wang L., Seike T., et al. Neuroprotective role of bradykinin because of the attenuation of pro-inflammatory cytokine release from activated microglia. J Neurochem 101 (2007) 397-410
25. Noda M., Sasaki K., Ifuku M., and Wada K. Multifunctional effects of bradykinin on glial cells in relation to potential anti-inflammatory effects. Neurochem Int 51 (2007) 185-191
26. Nomura T., Inamura T., and Black K.L. Intracarotid infusion of bradykinin selectively increases blood-tumor permeability in 9L and C6 brain tumors. Brain Res 659 (1994) 62-66
27. 2 receptors: normal distribution and alterations induced by epilepsy. J Comp Neurol 461 (2003) 506-519
28. Park C., Lee S., Cho I.H., Lee H.K., Kim D., Choi S.Y., et al. TLR3-mediated signal induces proinflammatory cytokine and chemokine gene expression in astrocytes: differential signaling mechanisms of TLR3-induced IP-10 and IL-8 gene expression. Glia 53 (2006) 248-256
29. Rodi D., Couture R., Ongali B., and Simonato M. Targeting kinin receptors for the treatment of neurological diseases. Curr Pharm Des 11 (2005) 1313-1326
30. Romera C., Hurtado O., Botella S.H., Lizasoain I., Cárdenas A., Fernández-Tomé P., et al. In vitro ischemic tolerance involves upregulation of glutamate transport partly mediated by the TACE/ADAM17-tumor necrosis factor-α pathway. J Neurosci 24 (2004) 1350-1357
31. 2 receptor ligand, incorporating a 4-aminoquinoline framework. Identification of a key pharmacophore to determine species difference and agonist/antagonist profile. J Med Chem 47 (2004) 2667-2677
32. Schwaninger M., Sallmann S., Petersen N., Schneider A., Prinz S., Libermann T.A., et al. Bradykinin induces interleukin-6 expression in astrocytes through activation of nuclear factor-κB. J Neurochem 73 (1999) 1461-1466
33. 2+, ErbB3, and phosphoinositide 3-kinase in 1321N1 astrocytoma cells. J Biol Chem 277 (2002) 338-344
34. Tzeng S.F., Kahn M., Liva S., and De Vellis J. Tumor necrosis factor-α regulation of the Id gene family in astrocytes and microglia during CNS inflammatory injury. Glia 26 (1999) 139-152
35. Uçeyler N., Eberle T., Rolke R., Birklein F., and Sommer C. Differential expression patterns of cytokines in complex regional pain syndrome. Pain 132 (2007) 195-205
36. Uddin J., Garcia H.H., Gilman R.H., Gonzalez A.E., and Friedland J.S. Monocyte-astrocyte networks and the regulation of chemokine secretion in neurocysticercosis. J Immunol 175 (2005) 3273-3281
37. Wang H., Kohno T., Amaya F., Brenner G.J., Ito N., Allchorne A., et al. Bradykinin produces pain hypersensitivity by potentiating spinal cord glutamatergic synaptic transmission. J Neurosci 25 (2005) 7986-7992
38. Westerholt S., Pieper A.K., Griebel M., Volk H.D., Hartung T., and Oberhoffer R. Characterization of the cytokine immune response in children who have experienced an episode of typical hemolytic-uremic syndrome. Clin Diagn Lab Immunol 10 (2003) 1090-1095